Literature DB >> 20599482

MicroRNAs and their implications in toxicological research.

Carolina Lema1, Mary Jane Cunningham.   

Abstract

MicroRNAs (miRNAs) are non-coding regulatory RNA molecules that bind target messenger RNAs (mRNA) and suppress their translation into proteins. When an organism is exposed to a toxic compound, cells respond by altering the pattern of gene expression, including miRNAs. Altered miRNA expression affects protein translation, which in turn alters cellular physiology causing adverse biological effects. Moreover, different types of cellular stress have been shown to affect miRNA expression as a mechanism of adaptation or tolerance to stress factors in order to survive. Besides an updated theoretical background concerning miRNAs biology, biogenesis, function, and roles in disease; this mini review provides an overview of miRNAs response to exogenous agents such as environmental stressors and toxic compounds. The implications of miRNAs in toxicogenomics as well as the new avenues of research of miRNAs in toxicology are discussed. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 20599482     DOI: 10.1016/j.toxlet.2010.06.019

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  25 in total

Review 1.  Environmental chemicals and microRNAs.

Authors:  Lifang Hou; Dong Wang; Andrea Baccarelli
Journal:  Mutat Res       Date:  2011-05-14       Impact factor: 2.433

2.  Modulation of miRNA-155 alters manganese nanoparticle-induced inflammatory response.

Authors:  Matthew W Grogg; Laura K Braydich-Stolle; Elizabeth I Maurer-Gardner; Natasha T Hill; Suraj Sakaram; Madhavi P Kadakia; Saber M Hussain
Journal:  Toxicol Res (Camb)       Date:  2016-10-13       Impact factor: 3.524

3.  Arsenic-exposed Keratinocytes Exhibit Differential microRNAs Expression Profile; Potential Implication of miR-21, miR-200a and miR-141 in Melanoma Pathway.

Authors:  Horacio Gonzalez; Carolina Lema; Robert A Kirken; Rosa A Maldonado; Armando Varela-Ramirez; Renato J Aguilera
Journal:  Clin Cancer Drugs       Date:  2015

4.  SNMFSMMA: using symmetric nonnegative matrix factorization and Kronecker regularized least squares to predict potential small molecule-microRNA association.

Authors:  Yan Zhao; Xing Chen; Jun Yin; Jia Qu
Journal:  RNA Biol       Date:  2019-11-27       Impact factor: 4.652

Review 5.  MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis.

Authors:  Alberto Izzotti; Cristina Cartiglia; Vernon E Steele; Silvio De Flora
Journal:  Mutat Res       Date:  2012-06-07       Impact factor: 2.433

6.  miR-200a-3p promotes b-Amyloid-induced neuronal apoptosis through down-regulation of SIRT1 in Alzheimer's disease.

Authors:  Qi-Shun Zhang; Wei Liu; Guang-Xiu Lu
Journal:  J Biosci       Date:  2017-09       Impact factor: 1.826

Review 7.  Targeting epigenetic mechanisms and microRNAs by aspirin and other non steroidal anti-inflammatory agents--implications for cancer treatment and chemoprevention.

Authors:  Eugenia Yiannakopoulou
Journal:  Cell Oncol (Dordr)       Date:  2014-07-05       Impact factor: 6.730

8.  MicroRNAs in Neurotoxicity.

Authors:  Prameet Kaur; Arunmozhiarasi Armugam; Kandiah Jeyaseelan
Journal:  J Toxicol       Date:  2012-03-06

9.  Hepatic mRNA, microRNA, and miR-34a-target responses in mice after 28 days exposure to doses of benzo(a)pyrene that elicit DNA damage and mutation.

Authors:  Amal I Malik; Andrew Williams; Christine L Lemieux; Paul A White; Carole L Yauk
Journal:  Environ Mol Mutagen       Date:  2011-10-02       Impact factor: 3.216

10.  Heart structure-specific transcriptomic atlas reveals conserved microRNA-mRNA interactions.

Authors:  Caterina Vacchi-Suzzi; Florian Hahne; Philippe Scheubel; Magali Marcellin; Valerie Dubost; Magdalena Westphal; Catherine Boeglen; Stine Büchmann-Møller; Ming Sin Cheung; André Cordier; Christopher De Benedetto; Mark Deurinck; Moritz Frei; Pierre Moulin; Edward Oakeley; Olivier Grenet; Armelle Grevot; Robert Stull; Diethilde Theil; Jonathan G Moggs; Estelle Marrer; Philippe Couttet
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.